ZIMMER BIOMET HOLDINGS, INC. Proceeds from (Payments for) Other Financing Activities
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Proceeds from (Payments for) Other Financing Activities of -$17.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsForOtherFinancingActivities · last filed 2026-08-05
- ZIMMER BIOMET HOLDINGS, INC. proceeds from (payments for) other financing activities for the quarter ending 2026-06-30 was -$2.30M.
- ZIMMER BIOMET HOLDINGS, INC. proceeds from (payments for) other financing activities for the quarter ending 2026-03-31 was -$15.60M.
- ZIMMER BIOMET HOLDINGS, INC. proceeds from (payments for) other financing activities for the quarter ending 2025-12-31 was -$1.10M.
- ZIMMER BIOMET HOLDINGS, INC. proceeds from (payments for) other financing activities for the quarter ending 2025-09-30 was -$500.00K, a 105.68% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. proceeds from (payments for) other financing activities for fiscal 2025 was -$17.70M.
- ZIMMER BIOMET HOLDINGS, INC. proceeds from (payments for) other financing activities for fiscal 2024 was -$22.40M.
- ZIMMER BIOMET HOLDINGS, INC. proceeds from (payments for) other financing activities for fiscal 2023 was -$10.10M.
- ZIMMER BIOMET HOLDINGS, INC. proceeds from (payments for) other financing activities for fiscal 2022 was -$4.50M.
| Period end | Proceeds from (Payments for) Other Financing Activities 3 month | Proceeds from (Payments for) Other Financing Activities 6 month | Proceeds from (Payments for) Other Financing Activities 6 month as first filed | Proceeds from (Payments for) Other Financing Activities 9 month | Proceeds from (Payments for) Other Financing Activities 9 month as first filed | Proceeds from (Payments for) Other Financing Activities 12 month | Proceeds from (Payments for) Other Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$17.90M 10-Q · filed 2026-08-05 | -$19.00M derived: sum of 3 quarters · filed 2026-08-05 | -$19.50M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | -$15.60M 10-Q · filed 2026-05-01 | -$16.70M derived: sum of 2 quarters · filed 2026-05-01 | -$17.20M derived: sum of 3 quarters · filed 2026-05-01 | -$18.10M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$1.60M derived: sum of 2 quarters · filed 2026-02-20 | -$2.50M derived: sum of 3 quarters · filed 2026-08-05 | -$17.70M 10-K · filed 2026-02-20 | |||
| 2025-09-30 | -$500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.40M derived: sum of 2 quarters · filed 2026-08-05 | -$16.60M 10-Q · filed 2025-11-05 | -$27.50M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | -$900.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$16.10M 10-Q · filed 2026-08-05 | -$27.00M derived: sum of 3 quarters · filed 2026-08-05 | -$18.20M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | -$15.20M 10-Q · filed 2026-05-01 | -$26.10M derived: sum of 2 quarters · filed 2026-05-01 | -$17.30M derived: sum of 3 quarters · filed 2026-05-01 | -$27.10M derived: sum of 4 quarters · filed 2026-05-01 | |||
| 2024-12-31 | -$10.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$2.10M derived: sum of 2 quarters · filed 2026-02-20 | -$11.90M derived: sum of 3 quarters · filed 2026-02-20 | -$22.40M 10-K · filed 2026-02-20 | |||
| 2024-09-30 | $8.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.00M derived: sum of 2 quarters · filed 2025-11-05 | -$11.50M 10-Q · filed 2025-11-05 | -$19.40M 10-Q · filed 2024-10-30 | -$14.80M derived: sum of 4 quarters · filed 2026-02-20 | ||
| 2024-06-30 | -$9.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$20.30M 10-Q · filed 2025-08-07 | -$12.50M 10-Q · filed 2024-08-07 | -$23.60M derived: sum of 3 quarters · filed 2026-02-20 | -$25.20M derived: sum of 4 quarters · filed 2026-02-20 | ||
| 2024-03-31 | -$10.50M 10-Q · filed 2025-05-05 | -$13.80M derived: sum of 2 quarters · filed 2026-02-20 | -$15.40M derived: sum of 3 quarters · filed 2026-02-20 | -$15.50M derived: sum of 4 quarters · filed 2026-02-20 | |||
| 2023-12-31 | -$3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$4.90M derived: sum of 2 quarters · filed 2026-02-20 | -$5.00M derived: sum of 3 quarters · filed 2026-02-20 | -$10.10M 10-K · filed 2026-02-20 | -$6.10M 10-K · filed 2024-02-23 | ||
| 2023-09-30 | -$1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$1.70M derived: sum of 2 quarters · filed 2024-10-30 | -$6.80M 10-Q · filed 2024-10-30 | -$5.90M derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2023-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$5.20M 10-Q · filed 2024-08-07 | -$4.30M derived: sum of 3 quarters · filed 2025-02-25 | -$6.20M derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2023-03-31 | -$5.10M 10-Q · filed 2024-05-02 | -$4.20M derived: sum of 2 quarters · filed 2025-02-25 | -$6.10M derived: sum of 3 quarters · filed 2025-02-25 | -$6.30M derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2022-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$1.00M derived: sum of 2 quarters · filed 2025-02-25 | -$1.20M derived: sum of 3 quarters · filed 2025-02-25 | -$4.50M 10-K · filed 2025-02-25 | |||
| 2022-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$2.10M derived: sum of 2 quarters · filed 2023-11-07 | -$5.40M 10-Q · filed 2023-11-07 | -$600.00K derived: sum of 4 quarters · filed 2024-08-07 | |||
| 2022-06-30 | -$200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$3.50M 10-Q · filed 2023-08-01 | $1.30M derived: sum of 3 quarters · filed 2024-08-07 | -$500.00K derived: sum of 4 quarters · filed 2024-08-07 | |||
| 2022-03-31 | -$3.30M 10-Q · filed 2023-05-02 | $1.50M derived: sum of 2 quarters · filed 2024-08-07 | -$300.00K derived: sum of 3 quarters · filed 2024-08-07 | -$4.10M derived: sum of 4 quarters · filed 2024-08-07 | |||
| 2021-12-31 | $4.80M derived: 8-K 12 month − 10-Q 9 month · filed 2024-08-07 | $3.00M derived: sum of 2 quarters · filed 2024-08-07 | -$800.00K derived: sum of 3 quarters · filed 2024-08-07 | -$6.30M 8-K · filed 2024-08-07 | |||
| 2021-09-30 | -$1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$5.60M derived: sum of 2 quarters · filed 2022-11-02 | -$11.10M 10-Q · filed 2022-11-02 | -$9.60M 10-Q · filed 2021-11-04 | -$12.70M derived: sum of 4 quarters · filed 2023-02-24 | ||
| 2021-06-30 | -$3.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$9.30M 10-Q · filed 2022-08-02 | -$10.90M derived: sum of 3 quarters · filed 2023-02-24 | -$11.50M derived: sum of 4 quarters · filed 2023-02-24 | |||
| 2021-03-31 | -$5.50M 10-Q · filed 2022-05-05 | -$7.10M derived: sum of 2 quarters · filed 2023-02-24 | -$7.70M derived: sum of 3 quarters · filed 2023-02-24 | -$7.80M derived: sum of 4 quarters · filed 2023-02-24 | |||
| 2020-12-31 | -$1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$2.20M derived: sum of 2 quarters · filed 2023-02-24 | -$2.30M derived: sum of 3 quarters · filed 2023-02-24 | -$8.30M 10-K · filed 2023-02-24 | |||
| 2020-09-30 | -$600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$700.00K derived: sum of 2 quarters · filed 2021-11-04 | -$6.70M 10-Q · filed 2021-11-04 | -$8.00M derived: sum of 4 quarters · filed 2022-06-22 | |||
| 2020-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$6.10M 10-Q · filed 2021-08-03 | -$7.40M derived: sum of 3 quarters · filed 2022-06-22 | -$7.90M derived: sum of 4 quarters · filed 2022-06-22 | |||
| 2020-03-31 | -$6.00M 10-Q · filed 2021-05-04 | -$7.30M derived: sum of 2 quarters · filed 2022-06-22 | -$7.80M derived: sum of 3 quarters · filed 2022-06-22 | -$8.50M derived: sum of 4 quarters · filed 2022-06-22 | |||
| 2019-12-31 | -$1.30M derived: 8-K 12 month − 10-Q 9 month · filed 2022-06-22 | -$1.80M derived: sum of 2 quarters · filed 2022-06-22 | -$2.50M derived: sum of 3 quarters · filed 2022-06-22 | -$6.70M 8-K · filed 2022-06-22 | -$10.20M 10-K · filed 2020-02-21 | ||
| 2019-09-30 | -$500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$1.20M derived: sum of 2 quarters · filed 2020-11-06 | -$5.40M 10-Q · filed 2020-11-06 | $3.70M derived: sum of 4 quarters · filed 2021-02-22 | |||
| 2019-06-30 | -$700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$4.90M 10-Q · filed 2020-08-05 | $4.20M derived: sum of 3 quarters · filed 2021-02-22 | $3.70M derived: sum of 4 quarters · filed 2021-02-22 | |||
| 2019-03-31 | -$4.20M 10-Q · filed 2020-05-11 | $4.90M derived: sum of 2 quarters · filed 2021-02-22 | $4.40M derived: sum of 3 quarters · filed 2021-02-22 | $4.10M derived: sum of 4 quarters · filed 2021-02-22 | |||
| 2018-12-31 | $9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $8.60M derived: sum of 2 quarters · filed 2021-02-22 | $8.30M derived: sum of 3 quarters · filed 2021-02-22 | $900.00K 10-K · filed 2021-02-22 | -$4.00M 10-K · filed 2019-02-26 | ||
| 2018-09-30 | -$500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$800.00K derived: sum of 2 quarters · filed 2019-11-05 | -$8.20M 10-Q · filed 2019-11-05 | ||||
| 2018-06-30 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$7.70M 10-Q · filed 2019-08-05 | |||||
| 2018-03-31 | -$7.40M 10-Q · filed 2019-05-06 | ||||||
| 2017-12-31 | -$8.60M 10-K · filed 2020-02-21 | ||||||
| 2016-12-31 | -$16.30M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |